Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: People with multiple sclerosis (MS) are at high risk of depression. We undertook a pilot trial of computerised cognitive behavioural therapy (CCBT) for the treatment of depression in people with MS to test the feasibility of undertaking a full trial. METHODS: Participants with a diagnosis of MS and clinical levels of depression were recruited through out-patient clinics and postal screening questionnaires at two UK centres and randomised to CCBT or usual care. Clinical outcomes included the Beck Depression Inventory (BDI-II) and Multiple Sclerosis Impact Scale (MSIS-29) at baseline, 8 and 21 weeks. Feasibility outcomes included: recruitment rate; reasons for refusal, withdrawal and dropout; feasibility and acceptability of the proposed outcome measures; sample size estimation and variation in and preferences for service delivery. RESULTS: Twenty-four participants were recruited. The recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who were consented into the trial, was 4.1%. Recruitment through out-patient clinics was somewhat slower than through screening questionnaire mail-out but the overall recruitment yield was similar. Of the 12 patients in the CCBT arm, 9 (75%) completed at least four, and 6 completed all 8 CCBT sessions. For completers, the median time (IQR) to complete all eight CCBT sessions was 15 (13 to 20) weeks. Participants expressed concern about the face validity of the Beck Depression Inventory II for the measurement of self-reported depression in people with MS. The MSIS-29 was the patient-reported outcome measure which participants felt best reflected their concerns. The estimated sample size for a full trial is between 180 and 390 participants. NHS partners were not delivering CCBT in community facilities and participants preferred to access CCBT at home, with no one expressing a preference for use of CCBT in an alternative location. CONCLUSIONS: A definitive trial, with a recruitment window of one year, would require the participation of around 13 MS centres. This number of centres could be reduced by expanding the eligibility criteria to include either other neurological conditions or people with more severe depression. The MSIS-29 should be used as a patient-important outcome measurement. TRIAL REGISTRATION: ISRCTN: ISRCTN81846800.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Sample size of 12 per group rule of thumb for a pilot study
Julious, S. A. (2005) · Pharmaceutical Statistics · doi:10.1002/pst.185 · Cited by 3,068
Improving the reporting of pragmatic trials: An extension of the CONSORT statement
Zwarenstein, M., Treweek, S., Gagnier, J. J., Altman, D. G., Tunis, S., Haynes, B., Oxman, A. D., Moher, D., & groups, F. T. C. A. P. T. I. H. (. (2008) · BMJ · doi:10.1136/bmj.a2390 · Cited by 1,813
Methods to increase response to postal and electronic questionnaires
Edwards, P. J., Roberts, I., Clarke, M. J., DiGuiseppi, C., Wentz, R., Kwan, I., Cooper, R., Felix, L. M., & Pratap, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000008.pub4 · Cited by 1,379
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.942 · Cited by 334
Kaltenthaler, E., Sutcliffe, P., Parry, G., Beverley, C., Rees, A., & Ferriter, M. (2008) · Psychological Medicine · doi:10.1017/s0033291707002607 · Cited by 267 · cited 1×
“52), which is comparable to dropout rates for other psychological therapies [30].”
BackgroundSelf-citationThe natural history of multiple sclerosis
Confavreux, C., & Compston, A. (2006) · McAlpine's Multiple Sclerosis · doi:10.1016/b978-0-443-07271-0.50006-9 · Cited by 166
Hind, D., O’Cathain, A., Cooper, C. L., Parry, G. D., Isaac, C. L., Rose, A., Martin, L., & Sharrack, B. (2010) · Psychology & Health · doi:10.1080/08870440902842739 · Cited by 101
Self-citation
Cited by
Fiest, K. M., Walker, J. R., Bernstein, C. N., Graff, L. A., Zarychanski, R., Abou-Setta, A. M., Patten, S. B., Sareen, J., Bolton, J. M., Marriott, J. J., et al. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.10.004 · Cited by 198
Watts, S. E., Turnell, A., Kladnitski, N., Newby, J. M., & Andrews, G. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.025 · Cited by 188
Hind, D., Cotter, J., Thake, A., Bradburn, M., Cooper, C., Isaac, C., & House, A. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-5 · Cited by 180
“A median of 45% (range 12% [30] to 71% [44]) of those approached about the study screened eligible (with the remainder in some studies refusing as well as failing screening).”
BackgroundMethodInfluentialSelf-citationWhite, V., Linardon, J., Stone, J. E., Holmes-Truscott, E., Olive, L., Mikocka-Walus, A., Hendrieckx, C., Evans, S., & Speight, J. (2022) · Psychological Medicine · doi:10.1017/s0033291720002251 · Cited by 90
Cooper, C. L., Whitehead, A., Pottrill, E., Julious, S. A., & Walters, S. J. (2018) · Clinical Trials · doi:10.1177/1740774517752113 · Cited by 59
Self-citation
Metadata
- Authors
- Cooper, C. L., Hind, D., Parry, G. D., Isaac, C. L., Dimairo, M., O'Cathain, A., Rose, A., Freeman, J. V., Martin, L., Kaltenthaler, E. C., Thake, A., & Sharrack, B.
- Venue
- Trials
- Published
- 2011-12
- Volume
- 12
- Issue
- 1
- Pages
- 259-259
- ISSN
- 1745-6215 (ISSN-L)
- OpenAlex
- W2157319576
- Cited by
- 61
- References
- 9
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial. https://app.cochat.ai/papers/10.1186/1745-6215-12-259
- The paper
- Cooper, C. L., Hind, D., Parry, G. D., Isaac, C. L., Dimairo, M., O'Cathain, A., Rose, A., Freeman, J. V., Martin, L., Kaltenthaler, E. C., Thake, A., & Sharrack, B. (2011). Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial. Trials. https://doi.org/10.1186/1745-6215-12-259
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.